Thomas Lienard
Direttore/Membro del Consiglio presso ANTIGON SA
Profilo
Thomas Lienard is currently a Director at Antigon SA since 2020.
Prior to this, he was the Chief Executive Officer, MD & Executive Director at Bone Therapeutics SA from 2016 to 2020.
He also held positions as Sales Director at Eli Lilly Benelux SA, Managing Director at Lundbeck SA, and Director at Prométhéa Asbl.
Mr. Lienard received an MBA from Harvard Business School in 2004 and a graduate degree from Solvay Business School of Economics & Management in 1999.
Posizioni attive di Thomas Lienard
Società | Posizione | Inizio |
---|---|---|
ANTIGON SA
ANTIGON SA Medical SpecialtiesHealth Technology Antigon SA is a Belgian medical information company that provides information on weight loss medications such as Saxenda, Ozempic, Wegovy, Rybelsus, Xenical, Mysimba, and Victoza. The company is based in Charleroi, Belgium. The company allows customers to buy these medications online with a medical prescription validated by doctors and have them delivered to their homes within 24 hours. Antigon was founded in 2016 by Francis Corazza, Hanane El Kenz, and Thierry Baltus. | Direttore/Membro del Consiglio | 01/07/2020 |
Precedenti posizioni note di Thomas Lienard
Società | Posizione | Fine |
---|---|---|
BIOSENIC SA | Amministratore Delegato | 01/01/2020 |
Eli Lilly Benelux SA
Eli Lilly Benelux SA Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Benelux SA is a pharmaceutical company based in Brussels, Belgium. The Belgian company focuses on research and development to discover and offer innovative medicines that improve the quality of life for people worldwide. Lilly has established policies, standards, and protective measures for the entire research and development process to ensure that the patient remains the top priority. The CEO of the company is Frederic Clais. | Vendite & Marketing | - |
Prométhéa Asbl | Direttore/Membro del Consiglio | - |
Lundbeck SA
Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Amministratore Delegato | - |
Formazione di Thomas Lienard
Harvard Business School | Masters Business Admin |
Solvay Business School of Economics & Management | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Eli Lilly Benelux SA
Eli Lilly Benelux SA Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Benelux SA is a pharmaceutical company based in Brussels, Belgium. The Belgian company focuses on research and development to discover and offer innovative medicines that improve the quality of life for people worldwide. Lilly has established policies, standards, and protective measures for the entire research and development process to ensure that the patient remains the top priority. The CEO of the company is Frederic Clais. | Health Technology |
Bone Therapeutics SA
Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium. | Health Technology |
Lundbeck SA
Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Health Technology |
Prométhéa Asbl | |
ANTIGON SA
ANTIGON SA Medical SpecialtiesHealth Technology Antigon SA is a Belgian medical information company that provides information on weight loss medications such as Saxenda, Ozempic, Wegovy, Rybelsus, Xenical, Mysimba, and Victoza. The company is based in Charleroi, Belgium. The company allows customers to buy these medications online with a medical prescription validated by doctors and have them delivered to their homes within 24 hours. Antigon was founded in 2016 by Francis Corazza, Hanane El Kenz, and Thierry Baltus. | Health Technology |
- Borsa valori
- Insiders
- Thomas Lienard